It is unclear whether BRCA1 and BRCA2-associated GC favors a particular subtype (i.e., diffuse versus intestinal), or if GC preferentially forms in a particular region of the stomach, as such granular details are typically underreported in the existing literature [1]. The gene discussed is BRCA1; the disease is gastric cancer.